Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Cet accord de licence permet à Novartis de progresser vers la réalisation de son objectif consistant à proposer des vaccins abordables et accessibles en vue de répondre à des besoins médicaux...
-
Lizenzvereinbarung unterstützt das Ziel von Novartis, zugängliche und erschwingliche Impfstoffe in Endemiegebieten mit ungedecktem medizinischen Bedarf bereitzustellen Weltweit werden...
-
License agreement advances a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions More than 21 million cases of typhoid fever and...
-
FIXTURE trial of more than 1,300 moderate-to-severe plaque psoriasis patients showed superiority of secukinumab (AIN457) to Enbrel® (etanercept) All primary and secondary endpoints were met ...
-
Lucentis® (ranibizumab) is the first licensed therapy to improve vision in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia Pivotal trial shows...
-
Omalizumab met all primary and secondary endpoints in pivotal GLACIAL study of patients with refractory chronic spontaneous urticaria (CSU)[1] Omalizumab found to be effective, safe and well...
-
Trial expected to support registration in the U.S. and European Union Sandoz continues to advance biosimilar pipeline with seven Phase III trials across five molecules Global program...
-
Recognition by the US Food and Drug Administration (FDA) that RLX030 has the potential to address a serious unmet medical need If approved, RLX030 has the potential to be the first treatment...
-
Der Basic Immunology Prize geht an Dr. Tim R. Mosmann und Robert L. Coffman. Durch Bestimmung von Untergruppen der T-Helferzellen haben sie zu einem besseren Verständnis von Infektions-, Autoimmun-...
-
The Basic Immunology Prize is awarded to Drs. Tim R. Mosmann and Robert L. Coffman for their work in defining subsets of T helper cells that advanced the understanding of infectious, autoimmune...